Literature DB >> 22151092

Programmable infusion pump and catheter: evaluation using 3-tesla magnetic resonance imaging.

Frank G Shellock1, Rocco Crivelli, Ramakrishna Venugopalan.   

Abstract

Objective.  This study assessed 3-Tesla magnetic resonance imaging (MRI) issues for a programmable infusion pump and associated catheters. Methods.  A programmable infusion pump and associated catheters (MedStream Programmable Infusion Pump, 40 mL; SureStream TI Coil-Reinforced Intraspinal Catheter; SureStream TI Connector; and SureStream Silicone Catheter; Codman and Shurtleff Inc., a Johnson & Johnson Company, Raynham, MA, USA) underwent evaluation for magnetic field interactions (deflection angle and torque), heating (transmit/receive body radiofrequency coil; whole-body averaged specific absorption rate, 3 W/kg for 15 min), functional changes (before and after MRI using eight different MRI conditions), and artifacts (T1-weighted spin-echo and gradient-echo pulse sequences) at 3-Tesla. Results.  The programmable infusion pump and associated catheters exhibited minor magnetic field interactions. Heating was not excessive (≤ 1.9°), especially considering the experimental conditions used for this evaluation (ie, relatively high radiofrequency power/specific absorption rate level and use of a nonperfused phantom). The function of three out of six pumps was temporarily altered by exposures to 3-Tesla MRI conditions. Reset was achieved in each case. Artifacts were relatively large for the pump and minor for the catheter. Conclusions.  The programmable infusion pump and catheters will not pose increased risk to a patient examined using 3-Tesla MRI as long as specific safety guidelines are followed, which includes interrogation of the pump post-MRI to ensure proper settings. Artifacts for the programmable infusion pump may impact the diagnostic use of MRI if the area of interest is in the same area or near the device.
© 2008 International Neuromodulation Society.

Entities:  

Year:  2008        PMID: 22151092     DOI: 10.1111/j.1525-1403.2008.00162.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  5 in total

1.  Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.

Authors:  D Dressler; S Berweck; A Chatzikalfas; M Ebke; B Frank; S Hesse; M Huber; J K Krauss; K-H Mücke; A Nolte; H-D Oelmann; P W Schönle; M Schmutzler; H Pickenbrock; C Van der Ven; N Veelken; M Vogel; T Vogt; F Adib Saberi
Journal:  J Neural Transm (Vienna)       Date:  2015-07-16       Impact factor: 3.575

Review 2.  [MR safety assessment of active implanted medical devices. German version].

Authors:  Sarra Aissani; Elmar Laistler; Jacques Felblinger
Journal:  Radiologe       Date:  2019-10       Impact factor: 0.635

Review 3.  MR safety assessment of active implantable medical devices.

Authors:  Sarra Aissani; Elmar Laistler; Jacques Felblinger
Journal:  Radiologe       Date:  2019-12       Impact factor: 0.635

4.  Injection And Infusion Technology Disruption For Use In MRI.

Authors:  M Kalmar; A Boese; R Landes; M Friebe
Journal:  Med Devices (Auckl)       Date:  2019-11-28

5.  Ventricular assist device implant (AB 5000) prototype cannula: in vitro assessment of MRI issues at 3-Tesla.

Authors:  Frank G Shellock; Samuel Valencerina
Journal:  J Cardiovasc Magn Reson       Date:  2008-05-21       Impact factor: 5.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.